White Papers
-
Optimizing Clinical Development Success In Hematologic Malignancies
11/12/2026
From choosing the right endpoints to identifying eligible patients from a limited pool, see what it takes to move a new therapy for leukemia, lymphoma, or myeloma from early-stage studies to approval.
-
AI In Precision Medicine: Predictive Insight To Operational Confidence
11/9/2026
Stop taking a reactive approach to trial delays. See how AI forecasting and connected lab and biomarker data help precision medicine teams spot problems sooner, with experts still making the calls.
-
Clinical Trial Starts Take Hit From 'Perfect Storm'
11/5/2026
Clinical trial initiations in 2025 declined 16% versus 2024, reflecting a convergence of regulatory upheaval, funding contractions, geopolitical tensions, and sweeping government restructuring.
-
Enrollment Rates Remain Low But Stable
11/5/2026
Overall industry-sponsored patient trial enrollment posted a combined median enrollment rate (MER) of 0.37 patients per site per month in the 2022–25 period, remaining relatively stable year to year.
-
Beyond Automation: Transforming Clinical Trial Delivery Through Structured Information
10/23/2026
Study build delays stem less from slow tasks than from protocol intent being reinterpreted at every handoff. Treating the protocol as structured, reusable information changes where AI and expertise belong.
-
Participant-Centric RTSM Designs: Supply Management For Advanced Therapies And DTP
10/23/2026
Advanced therapies and home trials require participant-centric supply systems that manage identity, short usability windows and PII from order through destruction.
-
In Search Of A Cure For Low Enrollment In Oncology Clinical Trials
10/19/2026
Delayed enrollment can cost oncology trials up to $250K per patient. Explore the barriers keeping patients out and practical ways to reach more of them faster.
-
The PMCF Decision Guide
10/14/2026
Proposed EU reforms may remove standalone PMCF reporting, yet the duty to proactively collect clinical data remains. Method selection, notified body defense, and data-capture cost determine what comes next.
-
Everything Clinical Trial Leaders Need To Know About AI Agents
10/13/2026
A practical guide to what agentic AI actually means for clinical trials, from ontologies and human-in-the-loop governance to continuous validation and the build-versus-buy decision.
-
What It Takes To Achieve Patient-Centric Clinical Trials
10/8/2026
Patient centricity is shifting from separate initiatives to a connected operating model. Survey data from sponsors, CROs, and sites show where fragmentation persists and what is required.